It is still unknown whether TRPV1 or TRPM8 is involved in controlling germline mutations of epigenetic modifiers in RB, yet Ca2+ signaling from nociceptive TRP channels may influence epigenetic mechanisms in determining non-aging-associated cancer development. The gene discussed is TRPV1; the disease is retinoblastoma.